Launch of Thomson Clinical Xpert Delivers Essential Medical Information to Physicians via PDAs

THOMSONThomson, a leading provider of clinical and management decision support solutions to healthcare professionals, announced the launch of Thomson Clinical Xpert™ for PDAs. A powerful new medical reference and decision-support tool, Thomson Clinical Xpert puts authoritative drug, disease and laboratory information instantly into the hands of physicians and other prescribers, nurses, pharmacists, and clinical trainees, helping them to make important decisions at the point of care, and reducing the chances of medical errors.

The launch of this new application, which will help address quality and safety issues such as drug interactions, comes at a time when medical errors and patient safety continue to be a national concern – one underscored by a recent report from the Institute of Medicine that noted medication errors alone still harm 1.5 million patients per year.

Whether in the hospital or a medical office, Thomson Clinical Xpert enhances healthcare professionals' ability to make the right decisions quickly, helping to avoid errors and improve the quality of care. Thomson, known and trusted by healthcare professionals as the company that produces the Physicians' Desk Reference® (PDR), developed Thomson Clinical Xpert to give healthcare professionals fast, convenient access to the evidence-based information they need to support or confirm diagnosis and treatment decisions. This release extends the commitment of Thomson to help improve medication safety wherever it is needed. Future Thomson Clinical Xpert releases will feature desktop and online access to additional workflow tools for medication reconciliation, pharmacy intervention and reporting, coding compliance and executable order sets.

Dr. Jerry Osheroff, chief clinical informatics officer at Thomson and lead author of the American Medical Informatics Association Roadmap for National Action on Clinical Decision Support, said Thomson Clinical Xpert will be a useful tool in efforts to improve the safety and quality of healthcare. "We know that clinicians are committed to eliminating errors and ensuring the most effective care for their patients," he said. "Thomson Clinical Xpert improves point-of-care access to consistent, authoritative medical knowledge for all those who play a direct role in patient care, reducing the risk of medical errors. The ultimate beneficiary is, of course, the patient."

Thomson Clinical Xpert features premium content from Thomson Micromedex, one of the most respected providers of evidence-based clinical information. Experienced physicians, pharmacists, toxicologists, nurses and other healthcare professionals at Micromedex develop and review Thomson Clinical Xpert content, giving clinicians information of unparalleled authority and accuracy, including:

  • A searchable database of more than 4,000 drugs with comprehensive indications, dosage and interactions information
  • Details on more than 400 laboratory tests and their interpretations
  • Toxicology reports on more than 200 of the most common poisons and drug overdoses
  • A comprehensive disease database that offers differential diagnoses, therapeutics and evidence-based recommendation ratings
  • Detailed information about alternative medicines

Thomson Clinical Xpert also features drug interaction tools, convenient medical calculators and "Xpert Alerts"— electronic advisories regarding key drug changes or treatment studies delivered directly to users PDA, desktop or PDR.net account.

Delaware family practitioner John Hale, M.D., said he uses Thomson Clinical Xpert on a daily basis to look up dosages, maximum dosages and drug interactions. "I use my PDA in the exam room without having to leave the room, or the discussion to look up pertinent information," he noted. "I also have used the lab and diagnosis sections while making rounds in the hospital. Having a library like this in my pocket PC is a real time saver."

Osheroff noted that a 2005 study found that more than 87 percent of physicians reported using PDAs, and as many as 50 percent say they frequently refer to PDA-stored clinical information. "As more and more clinicians rely on PDAs, combining the convenience of a PDA with comprehensive, accurate medical information provided by a trusted source such Thomson is going to be an invaluable tool to support clinical practice," he said.

For further information, please visit: www.thomsonclinicalxpert.com

About The Thomson Corporation
The Thomson Corporation (www.thomson.com) is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, scientific research and healthcare. The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Most Popular Now

AI Points the Way to Better Doctor-Patie…

A computer analysis of hundreds of thousands of secure email messages between doctors and patients found that most doctors use language that is too complex for their patients to understand...

Open Call DIGITAL-2021-DEPLOY-01-TWINS-H…

The development of digital twins in healthcare (DTH) has progressed substantially, profiting from advances in science and technology. In order to exploit their benefits in view of better prevention approaches...

Mayo Clinic Researchers Use AI, Biomarke…

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients...

Mjog by Livi Launches Remote Monitoring …

Mjog by Livi has launched a remote monitoring tool that will help GPs support and monitor people with depression through messages sent to their smartphones. The latest data from the Office...

Could EKGs Help Doctors use AI to Detect…

Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the Icahn School of Medicine at Mount Sinai showed for the first time that artificial intelligence (AI)...

Computer Model of Blood Enzyme

Membrane-associated proteins play a vital role in a variety of cellular processes, yet little is known about the membrane-association mechanism. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is one such protein with an...

4.5 Million Euros in EU Funding for Saar…

This year, three computer scientists from Saarbrücken were awarded an "ERC Starting Grant" by the European Research Council. This award, endowed with 1.5 million euros each, is among the most...

2022 EU4Health Work Programme Adopted to…

Today the Commission has adopted the second EU4Health work programme. In 2022, the EU4Health will continue to invest in building stronger, more resilient health systems and pave the way for...

Five NHS Trusts in Surrey and Sussex to …

A consortium of NHS trusts that covers a population of circa 1.2 million will gain immediate access to important patient imaging, and will mobilise a regional workforce for patients, following...

Helping Cancer Patients Avoid Excessive …

A Case Western Reserve University-led team of scientists has used Artificial Intelligence (AI) to identify which patients with certain head and neck cancers would benefit from reducing the intensity of...

The Programme for the Union's Action in …

On 24 March 2021, Regulation (EU) 2021/522 of the European Parliament and of the Council1 was adopted as part of the Multiannual Financial Framework for the 2021-2027 period. That Regulation...

CliniSys Acquires HORIZON Lab Systems an…

CliniSys is announcing the recent acquisition of HORIZON Lab Systems and the combination with Sunquest Information Systems, as CliniSys. This acquisition and Sunquest combination creates one of the world’s...